Skip to content
GLP-1 Decoder

GLP-1 for Seniors: Evidence, Eligibility, Coverage

The GLP-1 labels do not set separate rules for adults 65 and older: the approved uses are the same. In SELECT: the result was 6.5% for heart attack, stroke, or death from heart disease, vs 8% on placebo.

Best result (SELECT)
the result was 6.5% for heart attack, stroke, or death from heart disease
Medicare GLP-1 Bridge
$50 per month

Half-life and weight loss overview

How long each medicine stays in your body
Wegovy7 dOzempic7 dRybelsus7 dZepbound5.5 dMounjaro5 dTrulicity5 dFoundayo1.6 dSaxenda0.5 dVictoza0.5 dByetta0.1 d

Half-life in days tells how long your body needs to clear half of a dose. This comes from section 12.3 in every FDA label.

Main trial weight loss for each drug
Zepbound20.9%Wegovy14.9%Foundayo11.1%Saxenda7.4%

Percentage of body weight. Because trials, doses, and lengths differ, read each against its own placebo on the page listed for it.

Sources (10)

FDA label (DailyMed) 1 2 3 4 5 6 7 8 9 10.

Is GLP-1 approved for seniors?

GLP-1 medicines and older adults
MedicineFor older adultsHow it is takenTrial result
OzempicApproved uses applyweekly injectionNot listed
WegovyApproved uses applyweekly injection or daily tabletthe result was 6.5% for heart attack, stroke, or death from heart disease
RybelsusApproved uses applydaily tablet12% for a heart attack, a stroke, or death caused by heart disease
MounjaroApproved uses applyweekly injectionNot listed
ZepboundApproved uses applyweekly injectionNot listed
FoundayoApproved uses applydaily tabletNot listed
TrulicityApproved uses applyweekly injection12% for a heart attack, a stroke, or death caused by heart disease
SaxendaApproved uses applydaily injectionNot listed
VictozaApproved uses applydaily injectionNot listed
ByettaApproved uses applytwice-daily injectionNot listed

Cited here: FDA DailyMed label, PubMed.

Who qualifies?

GLP-1: who qualifies
Who sets the ruleWho qualifies
OzempicAdults with type 2 diabetes see lower blood sugar when taking it with diet and exercise.
OzempicAdults with type 2 diabetes and heart disease are less likely to have a heart attack, stroke, or heart-related death when they use this medicine.
OzempicIn adults with chronic kidney disease and type 2 diabetes, it lowers the risk that kidney disease gets worse, plus the risk of kidney failure and of death related to the heart.
WegovyFor adults with heart disease who also have obesity or overweight, it lowers the risk of heart attack, stroke, and heart-related death (injection and tablets).
WegovyLong term weight loss that stays off, through diet and activity, applies to children 12 and older and adults who have obesity, or adults who are overweight and have a weight-related condition.
WegovyThis injection provides treatment for adults who have MASH liver disease with moderate to advanced scarring and no cirrhosis.
WegovyFor adults, the tablets are approved for weight loss and heart risk.
RybelsusAdults with type 2 diabetes see lower blood sugar when taking it with diet and exercise.
RybelsusFor high-risk adults with type 2 diabetes, this medicine lowers the chance for a heart attack or stroke, plus death related to the heart.
MounjaroFor adults and children 10 and older with type 2 diabetes, this medicine lowers blood sugar when taken alongside diet and exercise.
MounjaroFor high-risk adults with type 2 diabetes, this medicine lowers the chance for a heart attack or stroke, plus death related to the heart.
ZepboundWith diet and activity, the use is long term weight loss and keeping it off for adults who have obesity, or adults who are overweight and have a weight-related condition.
ZepboundIt treats moderate to severe obstructive sleep apnea in adults who have obesity.
FoundayoWith diet and activity, the use is long term weight loss and keeping it off for adults who have obesity, or adults who are overweight and have a weight-related condition.
TrulicityFor adults and children 10 and older with type 2 diabetes, this medicine lowers blood sugar when taken alongside diet and exercise.
TrulicityAdults with type 2 diabetes and heart disease are less likely to have a heart attack, stroke, or heart-related death when they use this medicine or several heart risk factors.
SaxendaThe listed group includes children 12 and older (over 60 kg) and adults who have obesity, along with adults who are overweight and have a weight-related condition. Long term weight loss and keeping it off come with diet and activity.
VictozaFor adults and children 10 and older with type 2 diabetes, this medicine lowers blood sugar when taken alongside diet and exercise.
VictozaAdults with type 2 diabetes and heart disease are less likely to have a heart attack, stroke, or heart-related death when they use this medicine.
ByettaAdults with type 2 diabetes see lower blood sugar when taking it with diet and exercise.
Medicare GLP-1 BridgeBMI 35 or higher, no condition needed
Medicare GLP-1 BridgeCKD 3a+, heart failure or uncontrolled blood pressure, and a BMI of 30 or higher
Medicare GLP-1 BridgeYou need BMI 27 or higher, plus prediabetes, a prior heart attack or stroke, or PAD
Sources (12)

To see the FDA label on DailyMed, visit: 1 2 3 4 5 6 7 8 9 10. medicare.gov: 1 2.

What the trials found for seniors

GLP-1 trials in older adults
TrialMedicineWho took partLengthPeopleMain resultComparison
SELECT WegovyAdults aged 45 or older who had overweight or obesity and heart disease, but no diabetes39.8 months (follow-up)17,604the result was 6.5% for heart attack, stroke, or death from heart disease8% on placebo
SOUL RybelsusAdults aged 50 or older who had type 2 diabetes along with heart or kidney disease47.5 months (follow-up)9,65012% for a heart attack, a stroke, or death caused by heart disease13.8% on placebo
REWIND TrulicityAdults aged 50 or older who had type 2 diabetes, along with heart disease or risk factors5.4 years (follow-up)9,90112% for a heart attack, a stroke, or death caused by heart disease13.4% on placebo

Cited trials: SELECT (PubMed), SOUL (PubMed), REWIND (PubMed).

What is different for seniors?

GLP-1: label points for older adults
What changesWhat the label saysLabels
Low blood sugar with insulin secretagogues or insulin taken at the same timeTaking it with insulin or a sulfonylurea makes low blood sugar more likely, and those doses may need to be lowered.All of them
Acute Kidney Injury Due to Volume DepletionFluid loss from vomiting or diarrhea can lead to kidney injury. Drink fluids and report heavy fluid loss.All of them
Heart Rate IncreaseCan raise resting heart rate. If your heartbeat races or pounds while you are at rest, tell your doctor.Wegovy and Saxenda
Taken with insulin or sulfonylureasTaking it with insulin, or with a sulfonylurea such as glipizide or glimepiride, raises the chance of low blood sugar; your doctor may reduce those doses.All of them
Taken with warfarin and narrow-range drugsMedicines such as warfarin need closer monitoring when small changes in their levels matter.Mounjaro, Zepbound, Trulicity and Byetta

From the FDA labels come these FDA label (DailyMed) entries: 1 2 3.

The label gives these warnings: DailyMed FDA label.

Coverage for seniors

If prescribed, these medicines may be covered by Medicare Part D for diabetes or cardiovascular disease.

A GLP-1 may be covered by Part D plans for type 2 diabetes, sleep apnea that is moderate to severe, or fatty liver disease.

Medicare Part D does not pay for a GLP-1 when it is prescribed only for weight loss.

Wegovy is listed on the Medicare GLP-1 Bridge at $50 per month for people who meet its rules.

Where Medicaid covers weight-loss GLP-1s, you will usually need prior authorization.

Sources: humana.com, medicare.gov, CMS, KFF.

Questions to ask your prescriber